All
Older Adults with AML Don't Understand the Risks and Likely Outcomes of Treatment
October 24th 2017Older patients with acute myeloid leukemia (AML) often face a difficult choice: risky, intensive chemotherapy that offers a small chance of a cure versus non-intensive chemotherapy meant to improve physical comfort and quality of life.
Patients With Cancer Appreciate Undivided Attention From Doctors
October 24th 2017Specifically, the study demonstrated that patients with advanced cancer prefer that their physicians speak with them while holding a note pad, rather than while typing into computers that link to electronic health records.
Intervention Improves Psychosocial Wellbeing of Adolescent and Young Patients With Cancer
October 24th 2017Targeted intervention is effective in improving psychosocial stress experienced by many adolescent and young adult (AYA) patients with cancer, according to a study released ahead of the 2017 Palliative and Supportive Care in Oncology Symposium to be held Oct. 27-28 in San Diego.
Drug Combination Granted FDA Breakthrough Designation for Melanoma Treatment
October 23rd 2017The combination of Tafinlar (dabrafenib) and Mekinist (trametinib) was granted a breakthrough therapy designation by the Food and Drug Administration (FDA) for the adjuvant treatment of patients who have stage 3 melanoma and a BRAF V600 mutation, after they have already had a complete resection.